Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Lung cancer, non-small cell
Trial Type:  Treatment
Treatment/Intervention:  antiangiogenesis therapy
Trial Phase:  Phase III
Results 1-2 of 2 for your search:
Start Over
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Participants With EGFR Mutation-Positive Metastatic NSCLC
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 15540, NCI-2016-00365, 2014-004824-22, I4T-MC-JVCY, NCT02411448
Start Over